We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

AGC Acquires Biomeva

News   Sep 06, 2016

 
AGC Acquires Biomeva
 
 
Advertisement
 

RELATED ARTICLES

Peptide Combo Could Help Reduce Damage Caused By SARS-CoV-2

News

Two peptides once combined, work together to penetrate cells' membranes in order to dampen an acute inflammatory response. In this first ex vivo study, the peptide reduced collagen degradation. The researchers say the peptide could alleviate some of the worst damage caused by acute inflammatory responses.

READ MORE

Structural Cells Multi-task To Engage in Immune Response

News

Analyzing epigenetic and transcriptional regulation in structural cells, researchers found widespread activity of immune genes, suggesting that structural cells are deeply involved in the body’s response to pathogens.

READ MORE

Novel Pathology Could Improve Diagnosis and Treatment of Huntington’s Disease

News

Researchers have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington’s disease, and could be used to improve their diagnosis and treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE